propantheline has been researched along with Benign Neoplasms in 2 studies
Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, A | 1 |
| Saisho-Hattori, T | 1 |
| Koizumi, Y | 1 |
| Minegishi, M | 1 |
| Iinuma, K | 1 |
| Imaizumi, M | 1 |
| Selby, JV | 1 |
| Friedman, GD | 1 |
| Fireman, BH | 1 |
1 trial available for propantheline and Benign Neoplasms
| Article | Year |
|---|---|
Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pres | 2006 |
1 other study available for propantheline and Benign Neoplasms
| Article | Year |
|---|---|
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.
Topics: Anti-Bacterial Agents; Atropa belladonna; Carcinogens; Drug-Related Side Effects and Adverse Reactio | 1989 |